MedPath

[14C]-BGB-11417

Generic Name
[14C]-BGB-11417

A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2023-05-06
Last Posted Date
2025-04-17
Lead Sponsor
BeiGene
Target Recruit Count
6
Registration Number
NCT05844111
Locations
🇺🇸

Ppd Development, Lp, Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath